<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33258403</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1555-8584</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>RNA biology</Title>
          <ISOAbbreviation>RNA Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Silencing long non-coding RNA NEAT1 attenuates rheumatoid arthritis via the MAPK/ERK signalling pathway by downregulating microRNA-129 and microRNA-204.</ArticleTitle>
        <Pagination>
          <StartPage>657</StartPage>
          <EndPage>668</EndPage>
          <MedlinePgn>657-668</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/15476286.2020.1857941</ELocationID>
        <Abstract>
          <AbstractText>The participation of long noncoding RNAs (lncRNAs) and microRNAs (miRs) in the progression of rheumatoid arthritis (RA) is a key area of investigation. The current study aimed to investigate the action of lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) in fibroblast-like synoviocyte (FLS) proliferation and synovitis in RA. A rat model of RA was established. LncRNA NEAT1 expression in the synovial tissues of patients with RA and FLSs from the RA rat model was determined using RT-qPCR. Next, dual luciferase reporter gene assay was applied to investigate the relationship between miR-129/204 and mitogen-activated protein kinase (MAPK)/extracellular regulated protein kinase (ERK). A putative binding relationship between miR-204 and lncRNA NEAT1 was evaluated by RIP assay, and miR-129 promoter methylation was determined using MSP. After the expression of lncRNA NEAT1, miR-129 or miR-204 was altered in FLSs, the extent of ERK1/2 phosphorylation was assessed. In addition, FLS synovitis and proliferation were determined by ELISA and EdU assay, respectively. In RA rats, lncRNA NEAT1 was silenced and miR-129/miR-204 was overexpressed to explore their roles <i>in vivo</i>. LncRNA NEAT1 was upregulated, while miR-129 and miR-204 were downregulated in RA synovial tissues and FLSs. MAPK1 was target gene of both miR-129 and miR-204. LncRNA NEAT1 bound to miR-204 and promoted miR-129 promoter methylation. Silencing lncRNA NEAT1 or overexpressing miR-129/miR-204 enhanced miR-129/miR-204 expression, but reduced the extent of ERK1/2 phosphorylation, proliferation of FLSs, and synovitis in RA. Collectively, silencing lncRNA NEAT1 promoted miR-129 and miR-204 to inhibit the MAPK/ERK signalling pathway, reducing FLS synovitis in RA.<b>Abbreviations:</b> ACR: American College of Rheumatology; ELISA: Enzyme-linked immunosorbent assay; ERK: extracellular signal-regulated kinase; FLS: fibroblast-like synoviocyte; GADPH: glyceraldehyde-3-phosphate dehydrogenase; HRP: horseradish peroxidase; IFA: Incomplete Freund's Adjuvant; lncRNAs: long noncoding RNAs; MSP: Methylation-specific PCR; NC: negative control; NEAT1: nuclear paraspeckle assembly transcript 1; OD: optical density; RA: rheumatoid arthritis; RIPA: Radio Immunoprecipitation Assay; RLU: relative light units; RT-qPCR: reverse transcription quantitative polymerase chain reaction; UTR: untranslated region.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Xiao</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Mao</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Lihui</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Zixia</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Chengsong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology and Immunology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Yue</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>01</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>RNA Biol</MedlineTA>
        <NlmUniqueID>101235328</NlmUniqueID>
        <ISSNLinking>1547-6286</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C549404">MIRN204 microRNA, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C541915">Mirn129 microRNA, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C577276">NEAT1 long non-coding RNA, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.24</RegistryNumber>
          <NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000070918" MajorTopicYN="N">Synoviocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Long noncoding RNA nuclear paraspeckle assembly transcript 1</Keyword>
        <Keyword MajorTopicYN="Y">MAPK signalling pathway</Keyword>
        <Keyword MajorTopicYN="Y">fibroblast-like synoviocyte</Keyword>
        <Keyword MajorTopicYN="Y">microRNA-129</Keyword>
        <Keyword MajorTopicYN="Y">microRNA-204</Keyword>
        <Keyword MajorTopicYN="Y">rheumatoid arthritis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>8</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33258403</ArticleId>
        <ArticleId IdType="pmc">PMC8078539</ArticleId>
        <ArticleId IdType="doi">10.1080/15476286.2020.1857941</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29417936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aletaha D, Smolen JS.. 
Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360–1372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30285183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yap HY, Tee SZ, Wong MM, et al. Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells. 2018;7(10):161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6211121</ArticleId>
            <ArticleId IdType="pubmed">30304822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angelotti F, Parma A, Cafaro G, et al. One year in review 2017: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(3):368–378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28631608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan ZF, Zhao XY, Liu W, et al. UCA1 impacts progress of rheumatoid arthritis by inducing the apoptosis of fibroblast-like synoviocyte. Eur Rev Med Pharmacol Sci. 2018;22(4):914–920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29509238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang J, Chen W, Lin J.. 
LncRNA: an all-rounder in rheumatoid arthritis. J Transl Int Med. 2019;7(1):3–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6463828</ArticleId>
            <ArticleId IdType="pubmed">30997350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu D, Jiang Y, Yang L, et al. Long noncoding RNAs expression profile and functional networks in rheumatoid arthritis. Oncotarget. 2017;8(56):95280–95292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5707021</ArticleId>
            <ArticleId IdType="pubmed">29221127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Z, Li X, Jiang C, et al. Long non-coding RNAs in rheumatoid arthritis. Cell Prolif. 2018;51(1):e12404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6620844</ArticleId>
            <ArticleId IdType="pubmed">29110355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhang Z, Yu Z. Long non-coding RNA NEAT1 can predict various malignant tumour lympha node metastasis: a meta-analysis. Artif Cells Nanomed Biotechnol. 2019;47(1):2516–2520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31213091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou X, Li X, Yu L, et al. The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma. Int J Biochem Cell Biol. 2019;113:75–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31200124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Z, Dang J, Song A, et al. NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo. J Cell Physiol. 2019;234(11):19582–19591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31173354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia Y, Zhou Y, Han H, et al. lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3. J Cell Physiol. 2019;234(11):19592–19601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31173352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan J, Chen D, Chen X, et al. Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation. Braz J Med Biol Res. 2019;52(6):e8399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6556970</ArticleId>
            <ArticleId IdType="pubmed">31166382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shui X, Chen S, Lin J, et al. Knockdown of lncRNA NEAT1 inhibits Th17/CD4(+) T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477–22484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31119756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo PK, Zhang Y, Wolfson B, et al. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis. Oncotarget. 2016;7(40):65067–65089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5323139</ArticleId>
            <ArticleId IdType="pubmed">27556296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Qiu J, Chen B, et al. Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-kappaB pathway. Int Immunopharmacol. 2018;59:252–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29669307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai CH, Liu SC, Wang YH, et al. Osteopontin inhibition of miR-129-3p enhances IL-17 expression and monocyte migration in rheumatoid arthritis. Biochim Biophys Acta Gen Subj. 2017;1861(2):15–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27851983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B, Li N, Zhang L, et al. Hsa_circ_0001859 regulates ATF2 expression by functioning as an MiR-204/211 sponge in human rheumatoid arthritis. J Immunol Res. 2018;2018:9412387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5822876</ArticleId>
            <ArticleId IdType="pubmed">29577053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan YY, Wang YQ, Liu Y. CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway. J Cell Physiol. 2019;234(10):18748–18762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31066041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu F, Feng XX, Zhu SL, et al. Sonic hedgehog signaling pathway mediates proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via MAPK/ERK signaling pathway. Front Immunol. 2018;9:2847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6290332</ArticleId>
            <ArticleId IdType="pubmed">30568656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H, Ma R, Zou S, et al. Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritis. Mol Biosyst. 2017;13(6):1182–1192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28470264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaker OG, Mahmoud RH, Abdelaleem OO, et al. Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients. J Interferon Cytokine Res. 2019;39(3):174–180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30668267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Idogawa M, Nakase H, Sasaki Y, et al. Prognostic effect of long noncoding RNA NEAT1 expression depends on p53 mutation status in cancer. J Oncol. 2019;2019:4368068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6521466</ArticleId>
            <ArticleId IdType="pubmed">31186635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song J, Kim D, Han J, et al. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med. 2015;15(1):121–126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24722995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Xu YZ, Sun N, et al. Long noncoding RNA expression profile in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5053204</ArticleId>
            <ArticleId IdType="pubmed">27716329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang P, Wu T, Zhou H, et al. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. J Exp Clin Cancer Res. 2016;35:22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4731996</ArticleId>
            <ArticleId IdType="pubmed">26822763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong W, Yang J, Li M, et al. Long noncoding RNA NEAT1 promotes the growth of human retinoblastoma cells via regulation of miR-204/CXCR4 axis. J Cell Physiol. 2019;234(7):11567–11576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30479013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang L, Sun J, Pan Z, et al. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IkappaB. Am J Physiol Gastrointest Liver Physiol. 2017;313(2):G150–G156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28526689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Qian J, Li C, et al. miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle. 2010;9(9):1809–1818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20404570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu DM, Zhang YT, Lu J, et al. Effects of microRNA-129 and its target gene c-Fos on proliferation and apoptosis of hippocampal neurons in rats with epilepsy via the MAPK signaling pathway. J Cell Physiol. 2018;233(9):6632–6643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29194604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu R, Wang X, Hu Y, et al. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. Int J Oncol. 2019;54(5):1545–1554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6438418</ArticleId>
            <ArticleId IdType="pubmed">30864686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu F, Tai Y, Ma J. LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway. Cancer Biol Ther. 2018;19(6):534–542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5927658</ArticleId>
            <ArticleId IdType="pubmed">29565706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang F, Wu L, Qian J, et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J Autoimmun. 2016;75:96–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27481557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang SP, Guan X, Kai GY, et al. Broussonin E suppresses LPS-induced inflammatory response in macrophages via inhibiting MAPK pathway and enhancing JAK2-STAT3 pathway. Chin J Nat Med. 2019;17(5):372–380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31171272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Li J, Zhang J, et al. Sodium tanshinone IIA sulfonate inhibits proliferation, migration, invasion and inflammation in rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol. 2019;73:370–378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31132732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li ZZ, Tan JP, Wang LL, et al. Andrographolide benefits rheumatoid arthritis via inhibiting MAPK pathways. Inflammation. 2017;40(5):1599–1605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28584977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Xu N, Zhao S, et al. miR-410-3p suppresses cytokine release from fibroblast-like synoviocytes by regulating NF-kappaB signaling in rheumatoid arthritis. Inflammation. 2019;42(1):331–341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6394566</ArticleId>
            <ArticleId IdType="pubmed">30242542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arocho A, Chen B, Ladanyi M, et al. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 2006;15(1):56–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16531770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexopoulou AN, Leao M, Caballero OL, et al. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res. 2010;12(4):R51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2949640</ArticleId>
            <ArticleId IdType="pubmed">20642837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Zhang Z, Wang H, et al. Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3beta pathway. Mol Med Rep. 2016;14(3):2778–2784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27485139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim MA, Louie B, Ford D, et al. Development of the digital arthritis index, a novel metric to measure disease parameters in a rat model of rheumatoid arthritis. Front Pharmacol. 2017;8:818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5694443</ArticleId>
            <ArticleId IdType="pubmed">29184498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du J, Zhang F, Guo J. miR137 decreases proliferation, migration and invasion in rheumatoid arthritis fibroblastlike synoviocytes. Mol Med Rep. 2018;17(2):3312–3317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29257263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo T, Wang W, Zhang H, et al. ISL1 promotes pancreatic islet cell proliferation. PLoS One. 2011;6(8):e22387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3150357</ArticleId>
            <ArticleId IdType="pubmed">21829621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Q, Zhou D, Xu L, et al. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther. 2018;12:4095–4105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6284537</ArticleId>
            <ArticleId IdType="pubmed">30584274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu HM, Wang C, Yuan Z, et al. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p. Cell Prolif. 2019;52(1):e12526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6430453</ArticleId>
            <ArticleId IdType="pubmed">30407674</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
